Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled
Go back to Lexaria's GLP-1 Human Pilot Study #3 Completes Dosing as Scheduled| (NASDAQ: LEXX) | Delayed: 5.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.79 | 52 Week High | $ | |||
| Open | $5.79 | 52 Week Low | $ | |||
| Day High | $5.79 | P/E | N/A | |||
| Day Low | $5.79 | EPS | $ | |||
| Volume | 1,006 | |||||
| (NASDAQ: LEXXW) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $ | |||
| Open | $0.00 | 52 Week Low | $ | |||
| Day High | $0.00 | P/E | N/A | |||
| Day Low | $0.00 | EPS | $ | |||
| Volume | 1,006 | |||||
